跳至主要内容
临床试验/NCT00199069
NCT00199069已完成4 期

Multicenter Trial for Treatment of Acute Lymphoblastic Leukemia in Adults (05/93)

Goethe University1 个研究点 分布在 1 个国家目标入组 720 人开始时间: 1993年4月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
720
试验地点
1
主要终点
remission rate, disease free survival, overall survival

研究概览

简要总结

The study evaluates the efficacy and tolerability of a risk- and subtype-adapted chemotherapy over one year, followed by randomized either intensified or conventional maintenance therapy. It includes a distinct protocol for the subgroup 'mature B-ALL',

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute Lymphocytic Leukemia
  • Age 15 - 65 years

排除标准

  • Serious secondary diseases which may compromise intensified chemotherapeutical treatment
  • Serious psychiatric diseases, which may compromise compliance with therapy
  • HIV-1 or HIV-2 Infection
  • Pretreatment > 2 weeks or chemotherapy other than Vincristine and Steroids
  • Patients without central diagnosis who cannot be allocated to a risk group

结局指标

主要结局

remission rate, disease free survival, overall survival

次要结局

  • death in induction, toxicity, time and dose compliance

研究者

发起方
Goethe University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nicola Goekbuget

Study Coordinator

Goethe University

研究点 (1)

Loading locations...

相似试验